Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
expression is regulated by testosterone [RGD, Feb 2006].. Zusätzlich bieten wir Ihnen SCGB2A1 Antikörper (68) und SCGB2A1 Kits (6) und viele weitere Produktgruppen zu diesem Protein an.
Showing 5 out of 5 products:
The expression of HOXB13, IL17BR, and mammaglobin 1 in sentinel lymph nodes predict the outcome of primary breast cancer patients.
novel marker GATA3 stains a significantly higher proportion of both primary and metastatic breast carcinomas than GCDFP15 or mammaglobin with stronger and more diffuse staining, helpful in cases with small tissue samples
The commonly used breast carcinoma biomarkers vary in their prognostic implications. GCDFP-15 independently indicated a favourable prognosis. GATA-3 and MGB were not associated with outcome.
Results indicate that the quantitative analysis of h-MAM mRNA is a useful tool for detecting CTCs in breast cancer patients.
Results indicated that SCGB2A1 represented a novel, prognostic factor for colorectal cancer, and its expression correlated with chemoresistance, radioresistance and cancer cell stemness.
The data indicate that MGB1, MGB2 and LIPB mRNAs are expressed at low levels in human tissues but basal expression is upregulated in ovarian cancer.
SCGB2A1 is a top differentially expressed gene in all major histological types of ovarian cancers.
MGB has the highest expression in HER2-overexpressing breast cancers and may be a potentially useful marker for this subtype.
Data show that plasma mammaglobin mRNA alone or in combination with CA15.3 (CD227) may be used as a valuable noninvasive approach for the diagnosis and the detection of metastasis in breast cancer at the time of diagnosis.
The mammaglobin/lipophilin B complex is a promising diagnostic marker for breast cancer.
MGB2 markers may be useful for identifying micrometastases in sentinel lymph nodes of breast cancer patients.
SCGB 2A1 represents a new class of androgen target genes that are purely under indirect AR control mediated by DNA-bound Sp factors.
Results indicate that mammaglobin, as measured by the ELISA, holds significant promise for breast cancer screening with the realistic potential to impact management of this disease.
MGB-2 is highly expressed in endometrioid endometrial cancer [EEC], particularly in well- and moderately differentiated tumors, and may represent a novel molecular marker for EEC
Expression levels of mammaglobins A and B in nasal polyps are not different between patients with and without AR
MGB-2 expression characterizes less aggressive forms of EOC and is correlated with a favorable outcome
expression is regulated by testosterone
secretoglobin, family 2A, member 1
, lipophilin C
, mammaglobin 2
, mammaglobin B
, androgen receptor DNA-binding domain DNA
, prostatic steroid binding protein 1
, prostatic steroid binding protein, allele C3(2)
, prostatic steroid-binding protein 1
, prostatic steroid-binding protein C3.2
, secretoglobin family 2A member 1